CARL Stock Analysis: Buy, Sell, or Hold?
CARL - Carlsmed, Inc. Common Stock
$9.50
-0.16 (-1.66%)
▼
5d:
-8.65%
30d:
-34.8%
90d:
-30.71%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 30, 2026
30d
Get Alerted When CARL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CARL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CARL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CARL is currently trading at $9.50, which is considered oversold relative to its 30-day fair value range of $10.41 to $13.16.
Technical Outlook: Technically, CARL is in a downtrend. The price is currently testing key support at $9.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CARL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.60 (+102.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CARL is in a downtrend. The price is currently testing key support at $9.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CARL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.60 (+102.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$10.41 -
$13.16
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 102.9% below Wall St target ($19.60)
- CAUTION: 5-day price weakness (-8.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$10.41 -
$13.16
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$9.60
Resistance Level
$12.09
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.43
Wall Street Target
$19.60
(+102.9%)
Revenue Growth (YoY)
98.4%
Profit Margin
-57.5%
Share & Embed Analysis
Last updated: March 30, 2026 10:38 AM ET
Data refreshes hourly during market hours. Next update: 11:38 AM
Data refreshes hourly during market hours. Next update: 11:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CARL showing a specific setup today?
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 50 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 46 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 58 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 60 BUY |